
Proscia provides a comprehensive digital pathology platform named Concentriq, designed to help clinical laboratories and life sciences organizations transition from traditional glass slides to digital workflows. By bringing diagnostic data, images, and computational applications into a single enterprise environment, the platform supports clinical diagnostics, biomarker research, and pharmaceutical development.
Proscia is built for clinical laboratories, hospitals, clinics, and pharmaceutical companies looking to scale their digital pathology operations, unify distributed expert networks, and advance precision medicine initiatives.
Check the official website for current pricing.
Concentriq AP-Dx is cleared for primary clinical diagnosis to view, manage, review, and interpret digital images of scanned surgical pathology slides.
No, Concentriq AP-Dx is cleared for primary diagnosis, while Concentriq AP and Concentriq LS are restricted to research use only.